Rchr
J-GLOBAL ID:201901019890050148   Update date: Mar. 07, 2024

Kanako Saito

サイトウ カナコ | Kanako Saito
Affiliation and department:
Research field  (1): Tumor diagnostics and therapeutics
Research keywords  (3): 薬物療法 ,  Tumor Immunology ,  Breast Cancer
Research theme for competitive and other funds  (5):
  • 2021 - 2024 Development of a novel immunotherapy targeting GD2 for the treatment of refractory breast cancer
  • 2020 - 2023 Research on practical use of personalized targeting therapy in cancer using pharmacogenomic information and TDM
  • 2017 - 2020 Elucidation of breast cancer lung metastasis by IL-17 through the modulation of stromal cells and the development of treatment model
  • 2012 - 2012 IL-17による乳癌微小環境形成と転移促進作用の機序解明
  • 2009 - 2010 Induction of HER2-specific cellular immunity after trastuzumab therapy
Papers (54):
  • Yoshinaga Okugawa, Takahito Kitajima, Takumi Fujiwara, Emi Teramoto, Maki Nakamura, Makoto Ikejiri, Ryotaro Hashizume, Hiroshi Imai, Yasutaka Tono, Kanako Saito, et al. MO16-3 Clinical relevance of comprehensive genome profiling using real-world data in colorectal cancer. Annals of Oncology. 2023. 34. S1406-S1406
  • Akira Tsunoda, Koshi Sukeno, Hiroki Oka, Yasutaka Tono, Mikiya Ishihara, Kanako Saito, Satoshi Tamaru, Yoshiki Yamashita, Toshiro Mizuno, Isao Tawara. P40-3 Retrospective analysis of amrubicin therapy for advanced or recurrent neuroendocrine carcinoma in our facility. Annals of Oncology. 2023. 34. S1456-S1456
  • Yasutaka Tono, Koushi Sukeno, Akira Tsunoda, Hiroki Oka, Mikiya Ishihara, Kanako Saito, Satoshi Tamaru, Yoshiki Yamashita, Takumi Fujiwara, Takahito Kitajima, et al. MO36-3 Clinical management of cancer of unknown primary with unfavorable subset: A retrospective analysis. Annals of Oncology. 2023. 34. S1419-S1419
  • Chihiro Higashi, Kanako Saito, Yuji Kozuka, Hiroto Yuasa, Kaho Nakamura, Makoto Ishitobi, Mikiya Ishihara, Toshiro Mizuno, Isao Tawara, Hiroshi Fujiwara, et al. Ganglioside GD2 Expression Is Associated With Unfavorable Prognosis in Early Triple-negative Breast Cancer. Anticancer research. 2023. 43. 9. 4045-4053
  • Natsumi Kobayashi, Yasutaka Tono, Akira Tsunoda, Hiroki Oka, Kanako Saito, Yoshiki Yamashita, Toshiro Mizuno, Isao Tawara. [Interstitial Lung Disease after OK-432 Pleurodesis for Malignant Pleural Effusion in Breast Cancer-A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy. 2023. 50. 2. 183-186
more...
MISC (55):
  • 藤原拓海, 藤原拓海, 奥川喜永, 北嶋貴仁, 齋木晴子, 戸野泰孝, 藤本源, 齋藤佳菜子, 橋詰令太郎, 今井裕, et al. A case of renal pelvic cancer treated with afatinib after reconsidering pathological diagnosis based on findings of CGP. 日本臨床腫瘍学会学術集会(CD-ROM). 2022. 19th
  • 角田瑛, 祐野航志, 岡弘毅, 北嶋貴仁, 戸野泰孝, 石原幹也, 横江毅, 斎藤佳菜子, 田丸智巳, 山下芳樹, et al. A Retrospective Analysis of the Treatment of Esophagogastric Junction Adenocarcinoma in Our Facility. 日本臨床腫瘍学会学術集会(CD-ROM). 2022. 19th
  • Toshiaki Kobayashi, Hiroyasu Oda, Koushi Sukeno, Akira Tsunoda, Yasutaka Tono, Mikiya Ishihara, Kanako Saito, Yoshiki Yamashita, Toshiro Mizuno. Retrospective analysis of the efficacy and safety of nivolumab in patients with treatment-refractory esophageal cancer. ANNALS OF ONCOLOGY. 2021. 32. S328-S328
  • Koshi Sukeno, Akira Tsunoda, Yasutaka Tono, Hiroyasu Oda, Mikiya Ishihara, Kanako Saito, Satoshi Tamaru, Yoshiki Yamashita, Toshiro Mizuno. Retrospective analysis of the efficacy and safety of FOLFOX in patients with esophageal cancer. ANNALS OF ONCOLOGY. 2021. 32. S329-S329
  • 戸野泰孝, 斎藤佳菜子, 角田瑛, 小田裕靖, 石原幹也, 山下芳樹, 水野聡朗. 低血糖発作の制御に難渋した孤立性線維性腫瘍の一例. 日本臨床腫瘍学会学術集会(CD-ROM). 2019. 17th
more...
Association Membership(s) (6):
JAPAN SOCIETY OF CLINICAL ONCOLOGY ,  American Society of Clinical Oncology ,  Japanese Breast Cancer Society ,  Japanese Society of Medical Oncology ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page